230 related articles for article (PubMed ID: 2555560)
21. Cell clones cured of persistent poliovirus infection display selective permissivity to the wild-type poliovirus strain Mahoney and partial resistance to the attenuated Sabin 1 strain and Mahoney mutants.
Calvez V; Pelletier I; Couderc T; Pavio-Guédo N; Blondel B; Colbère-Garapin F
Virology; 1995 Oct; 212(2):309-22. PubMed ID: 7571400
[TBL] [Abstract][Full Text] [Related]
22. Mapping of sequences required for mouse neurovirulence of poliovirus type 2 Lansing.
La Monica N; Meriam C; Racaniello VR
J Virol; 1986 Feb; 57(2):515-25. PubMed ID: 3003384
[TBL] [Abstract][Full Text] [Related]
23. Mutations in VP1 of poliovirus specifically affect both encapsidation and release of viral RNA.
Kirkegaard K
J Virol; 1990 Jan; 64(1):195-206. PubMed ID: 2152812
[TBL] [Abstract][Full Text] [Related]
24. Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis.
Georgescu MM; Balanant J; Macadam A; Otelea D; Combiescu M; Combiescu AA; Crainic R; Delpeyroux F
J Virol; 1997 Oct; 71(10):7758-68. PubMed ID: 9311861
[TBL] [Abstract][Full Text] [Related]
25. Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine.
Bouchard MJ; Lam DH; Racaniello VR
J Virol; 1995 Aug; 69(8):4972-8. PubMed ID: 7609067
[TBL] [Abstract][Full Text] [Related]
26. Attenuation stem-loop lesions in the 5' noncoding region of poliovirus RNA: neuronal cell-specific translation defects.
Haller AA; Stewart SR; Semler BL
J Virol; 1996 Mar; 70(3):1467-74. PubMed ID: 8627664
[TBL] [Abstract][Full Text] [Related]
27. Host range phenotype induced by mutations in the internal ribosomal entry site of poliovirus RNA.
Shiroki K; Ishii T; Aoki T; Ota Y; Yang WX; Komatsu T; Ami Y; Arita M; Abe S; Hashizume S; Nomoto A
J Virol; 1997 Jan; 71(1):1-8. PubMed ID: 8985316
[TBL] [Abstract][Full Text] [Related]
28. A new cis-acting element for RNA replication within the 5' noncoding region of poliovirus type 1 RNA.
Shiroki K; Ishii T; Aoki T; Kobashi M; Ohka S; Nomoto A
J Virol; 1995 Nov; 69(11):6825-32. PubMed ID: 7474095
[TBL] [Abstract][Full Text] [Related]
29. Nucleic acid sequence of the region of the genome encoding capsid protein VP1 of neurovirulent and attenuated type 3 polioviruses.
Stanway G; Cann AJ; Hauptmann R; Mountford RC; Clarke LD; Reeve P; Minor PD; Schild GC; Almond JW
Eur J Biochem; 1983 Oct; 135(3):529-33. PubMed ID: 6311539
[TBL] [Abstract][Full Text] [Related]
30. Three poliovirus 2B mutants exhibit noncomplementable defects in viral RNA amplification and display dosage-dependent dominance over wild-type poliovirus.
Johnson KL; Sarnow P
J Virol; 1991 Aug; 65(8):4341-9. PubMed ID: 1649334
[TBL] [Abstract][Full Text] [Related]
31. Genetic variation occurring on the genome of an in vitro insertion mutant of poliovirus type 1.
Kuge S; Kawamura N; Nomoto A
J Virol; 1989 Mar; 63(3):1069-75. PubMed ID: 2536821
[TBL] [Abstract][Full Text] [Related]
32. A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain.
Kohara M; Abe S; Komatsu T; Tago K; Arita M; Nomoto A
J Virol; 1988 Aug; 62(8):2828-35. PubMed ID: 2839704
[TBL] [Abstract][Full Text] [Related]
33. Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome.
Evans DM; Dunn G; Minor PD; Schild GC; Cann AJ; Stanway G; Almond JW; Currey K; Maizel JV
Nature; 1985 Apr 11-17; 314(6011):548-50. PubMed ID: 2986004
[TBL] [Abstract][Full Text] [Related]
34. Strong inclination toward transition mutation in nucleotide substitutions by poliovirus replicase.
Kuge S; Kawamura N; Nomoto A
J Mol Biol; 1989 May; 207(1):175-82. PubMed ID: 2544735
[TBL] [Abstract][Full Text] [Related]
35. Construction and properties of intertypic poliovirus recombinants: first approximation mapping of the major determinants of neurovirulence.
Agol VI; Grachev VP; Drozdov SG; Kolesnikova MS; Kozlov VG; Ralph NM; Romanova LI; Tolskaya EA; Tyufanov AV; Viktorova EG
Virology; 1984 Jul; 136(1):41-55. PubMed ID: 6330995
[TBL] [Abstract][Full Text] [Related]
36. The deletion of 41 proximal nucleotides reverts a poliovirus mutant containing a temperature-sensitive lesion in the 5' noncoding region of genomic RNA.
Dildine SL; Semler BL
J Virol; 1989 Feb; 63(2):847-62. PubMed ID: 2536107
[TBL] [Abstract][Full Text] [Related]
37. Nucleotide sequence of a neurovirulent variant of the type 2 oral poliovirus vaccine.
Pollard SR; Dunn G; Cammack N; Minor PD; Almond JW
J Virol; 1989 Nov; 63(11):4949-51. PubMed ID: 2552175
[TBL] [Abstract][Full Text] [Related]
38. An RNA hairpin at the extreme 5' end of the poliovirus RNA genome modulates viral translation in human cells.
Simoes EA; Sarnow P
J Virol; 1991 Feb; 65(2):913-21. PubMed ID: 1846205
[TBL] [Abstract][Full Text] [Related]
39. Construction of a "mutagenesis cartridge" for poliovirus genome-linked viral protein: isolation and characterization of viable and nonviable mutants.
Kuhn RJ; Tada H; Ypma-Wong MF; Dunn JJ; Semler BL; Wimmer E
Proc Natl Acad Sci U S A; 1988 Jan; 85(2):519-23. PubMed ID: 2829191
[TBL] [Abstract][Full Text] [Related]
40. A poliovirus 2A(pro) mutant unable to cleave 3CD shows inefficient viral protein synthesis and transactivation defects.
Ventoso I; Carrasco L
J Virol; 1995 Oct; 69(10):6280-8. PubMed ID: 7666528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
